RT Journal Article
SR Electronic
A1 Rizzo, Toni
T1 Improving Outcomes in HF and Aortic Valve Stenosis with Advanced Technologies
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 24
SP 23
OP 23
DO 10.1177/155989771424016
UL http://mdc.sagepub.com/content/14/24/23.abstract
AB This article discusses advanced treatments for heart failure (HF) and severe aortic stenosis (SAS). Patients with advanced HF require special intervention, including left ventricular assist device (LVAD) implantation. Studies of the HeartMate II LVAD reported 79% to 90% rates of survival to transplant, recovery, or ongoing device support at 180 days [John R et al. Ann Thorac Surg 2011; Starling RC et al. J Am Coll Cardiol 2011; Pagani FD et al. J Am Coll Cardiol 2009; Miller LW et al. N Engl J Med 2007] and 58% to 63% 2-year survival [Park SJ et al. Circ Heart Fail 2012; Slaughter MS et al. N Engl J Med 2009].